# Wayne Shiong

> Wayne Shiong is a Series A investor at Singleron Biotechnologies backing Software and Life Science. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Singleron Biotechnologies](https://shizune.co/investors/profile/singleron-biotechnologies)
- Location: Beijing, China
- Total investments: 2
- Last investment: Sep 2020
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/wayneshiong/
- X (Twitter): https://twitter.com/wayneshiong
- Website: http://www.chinagrowthcapital.com/en

Wayne Shiong is a Series A investor at Singleron Biotechnologies in Beijing focused on Software and Life Science. Wayne Shiong is the Partner of China Growth Capital. Wayne attended Peking University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 1 | 50% |
| Life Science | 1 | 50% |
| Biotechnology | 1 | 50% |
| Information Services | 1 | 50% |
| Information Technology | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| InxMed | InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equippedwith global-level top-notch know-how and efficient execution capabilities. | $19M | Series A | Sep 04, 2020 |  |
| DeePhi Tech | Founded in 2016, DeePhi Tech aims to be a recognized leader in deep learning acceleration. They provide end-to-end solutions utilizing deep compression and a DPU platform. Through synergistic optimization of neural networks and FPGAs, DeePhi provides more efficient, convenient and economical inference platforms for both embedded end and sever-side,including but not limited to data centers and surveillance. | $40M | Series A | Oct 24, 2017 |  |

2 of 2 investments shown.

## Co-investors
- [Ant Group](https://shizune.co/investors/profile/ant-group) — VC Fund, 1 deal together
- [China Merchants Venture Capital](https://shizune.co/investors/profile/china-merchants-capital) — VC Fund, 1 deal together
- [Ennovation Ventures](https://shizune.co/investors/profile/ennovation-ventures) — VC Fund, 1 deal together
- [Grand Yangtze Capital](https://shizune.co/investors/profile/grand-yangtze-capital) — VC Fund, 1 deal together
- [InnoMed Capital](https://shizune.co/investors/profile/innomed-capital) — VC Fund, 1 deal together
- [Samsung Electronics](https://shizune.co/investors/profile/samsung-electronics) — VC Fund, 1 deal together

## About Singleron Biotechnologies

VC Fund · Nanjing, China

Singleron Biotechnologies is a developer and provider of clinical diagnosis, health management and drug development products and services. The company is dedicated to applying single cell analysis techniques and has obtained a world wide exclusive IP license from Yale University for its uniquely designed microfluidic single cell processing device,and has developed the innovative SCOPE single-cell pre-sequencing preparation system based on this microfluidic device.

5 contacts available at Singleron Biotechnologies.

| Name | Title | Profile |
| --- | --- | --- |
| Andreas Schmidt | Senior Vice President, Global Business Development | https://shizune.co/investors/profile/andreas-schmidt-2 |
| Jing Zhou | Founder &Vice President Of Engineering | https://shizune.co/investors/profile/jing-zhou-e98d |
| Nan Fang | Founder and Chief Executive Officer | https://shizune.co/investors/profile/nan-fang |
| Wayne Shiong | Investor | https://shizune.co/investors/profile/wayne-shiong |
| Yifeng Gao | Chief Financial Officer | https://shizune.co/investors/profile/yifeng-gao-f1ad |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Wayne Shiong invest in?

Wayne Shiong invests primarily in Software, Life Science and Biotechnology startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Wayne Shiong last invest?

The most recent investment recorded for Wayne Shiong closed in Sep 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co